Longyi Zeng

2.2k total citations
48 papers, 445 citations indexed

About

Longyi Zeng is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Longyi Zeng has authored 48 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Longyi Zeng's work include Diabetes Management and Research (17 papers), Metabolism, Diabetes, and Cancer (16 papers) and Diabetes Treatment and Management (12 papers). Longyi Zeng is often cited by papers focused on Diabetes Management and Research (17 papers), Metabolism, Diabetes, and Cancer (16 papers) and Diabetes Treatment and Management (12 papers). Longyi Zeng collaborates with scholars based in China, United States and Singapore. Longyi Zeng's co-authors include Panwei Mu, Jianping Weng, Hongyun Lu, Hongyun Lu, Biao Liang, Xiaochun Shu, Wen Xu, Shuo Lin, Xiaofeng Li and Manman Wang and has published in prestigious journals such as The Lancet, Diabetes and Cell Reports.

In The Last Decade

Longyi Zeng

46 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longyi Zeng China 12 246 166 109 90 55 48 445
Panwei Mu China 12 165 0.7× 177 1.1× 78 0.7× 69 0.8× 71 1.3× 24 449
Tina Kienitz Germany 13 329 1.3× 122 0.7× 77 0.7× 106 1.2× 49 0.9× 35 547
Yuzhen Liang China 14 137 0.6× 117 0.7× 103 0.9× 57 0.6× 78 1.4× 29 426
Dalong Zhu China 14 194 0.8× 169 1.0× 175 1.6× 94 1.0× 169 3.1× 26 545
Tomislav Bulum Croatia 12 203 0.8× 99 0.6× 109 1.0× 86 1.0× 51 0.9× 86 502
Zilin Sun China 14 123 0.5× 137 0.8× 48 0.4× 150 1.7× 65 1.2× 25 493
Linqiang Ma China 15 298 1.2× 211 1.3× 118 1.1× 255 2.8× 73 1.3× 29 671
John L. Petrie United Kingdom 10 108 0.4× 180 1.1× 67 0.6× 143 1.6× 42 0.8× 10 366
Laura Alba United States 8 274 1.1× 109 0.7× 305 2.8× 179 2.0× 65 1.2× 17 524
Kikuko Amo Japan 7 221 0.9× 276 1.7× 144 1.3× 153 1.7× 147 2.7× 9 765

Countries citing papers authored by Longyi Zeng

Since Specialization
Citations

This map shows the geographic impact of Longyi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longyi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longyi Zeng more than expected).

Fields of papers citing papers by Longyi Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longyi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longyi Zeng. The network helps show where Longyi Zeng may publish in the future.

Co-authorship network of co-authors of Longyi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Longyi Zeng. A scholar is included among the top collaborators of Longyi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longyi Zeng. Longyi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wen, et al.. (2025). Insulin Requirement Profiles of Short‐Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy. International Journal of Endocrinology. 2025(1). 8403917–8403917. 1 indexed citations
2.
Yang, Yanling, et al.. (2024). Relationship between hemoglobin glycation index and risk of hypoglycemia in type 2 diabetes with time-in-range in target. World Journal of Diabetes. 15(10). 2058–2069. 3 indexed citations
3.
Ritzel, Robert, Sujoy Ghosh, Rıfat Emral, et al.. (2023). Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics. Diabetes Obesity and Metabolism. 25(9). 2495–2504. 3 indexed citations
4.
Cao, Huanyi, Qiao Su, Hancheng Qin, et al.. (2023). Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD. Cell Reports. 42(4). 112319–112319. 21 indexed citations
5.
Wang, Nana, Bowen Zheng, Tao Wu, et al.. (2021). Thyroid dysfunction following radiofrequency ablation for benign thyroid nodules: more likely to occur within one-week and in high-risk population. International Journal of Hyperthermia. 38(1). 1060–1068. 10 indexed citations
6.
Yang, Xubin, Wen Xu, Yanhua Zhu, et al.. (2018). Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes. Neuroscience Bulletin. 35(1). 25–33. 5 indexed citations
7.
Xu, Zhangrong, Linong Ji, Lixin Guo, et al.. (2018). Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study. Journal of Diabetes Investigation. 10(2). 539–551. 34 indexed citations
8.
9.
Li, Haicheng, Haixia Xu, Fen Xu, et al.. (2018). The effects of caveolin1 on β cell proliferation. Cellular and Molecular Biology. 64(1). 40–46. 3 indexed citations
10.
Xu, Wen, Yiming Mu, Jiajun Zhao, et al.. (2017). Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial. Science China Life Sciences. 60(3). 225–238. 8 indexed citations
11.
Mu, Panwei, Ping Jiang, Manman Wang, et al.. (2016). Oestrogen exerts anti-inflammation via p38 MAPK/NF-κB cascade in adipocytes. Obesity Research & Clinical Practice. 10(6). 633–641. 19 indexed citations
12.
Zhu, Yanhua, Daizhi Yang, Jin Li, et al.. (2015). Insulin sensitivity in a patient with Prader-Willi syndrome. 4(3). 159–161. 1 indexed citations
13.
Xu, Wen, Sihui Luo, Haixia Xu, et al.. (2015). Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. Acta Diabetologica. 52(6). 1083–1091. 47 indexed citations
14.
Wang, Manman, Shuo Lin, Yanming Chen, et al.. (2015). Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin. Diabetes Research and Clinical Practice. 108(3). e67–e70. 11 indexed citations
15.
Lu, Hongyun, et al.. (2013). [Primary culturing and effects of insulin glargine on proliferation, differentiation of human preadipocytes from subcutaneous and omental adipose tissue].. PubMed. 93(36). 2861–6. 1 indexed citations
16.
17.
18.
Mu, Panwei, Zhi Tan, Yuhong Cui, et al.. (2010). 17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3. Irish Journal of Medical Science (1971 -). 180(1). 221–227. 5 indexed citations
19.
Lu, Hongyun, et al.. (2009). High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease. Archives of Medical Research. 40(7). 571–575. 57 indexed citations
20.
Bi, Yan, Jinhua Yan, Zhihong Liao, et al.. (2008). Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China. Chinese Medical Journal. 121(8). 677–681. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panwei Mu Breakdown of academic impact, for papers by Tina Kienitz Breakdown of academic impact, for papers by Yuzhen Liang Breakdown of academic impact, for papers by Dalong Zhu Breakdown of academic impact, for papers by Tomislav Bulum Breakdown of academic impact, for papers by Zilin Sun Breakdown of academic impact, for papers by Linqiang Ma Breakdown of academic impact, for papers by John L. Petrie Breakdown of academic impact, for papers by Laura Alba Breakdown of academic impact, for papers by Kikuko Amo
Rankless by CCL
2026